GlaxoSmithKline Pharmaceuticals has launched Jemperli and Zejula in India, pioneering precision therapies for gynaecological ...

GlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological ...

GSK enters oncology with Jemperli & Zejula for gynaecological cancers in India. Advanced therapies address unmet needs in ...

Jemperli is the first and only approved programmed death receptor-1 (PD-1) immunotherapy for the second-line treatment of ...

GlaxoSmithKline (GSK) has entered India's oncology sector with the launch of Jemperli and Zejula. These therapies address the increasing need for specialized cancer treatments.

GlaxoSmithKline (GSK) has announced its foray into oncology in India with the launch of Jemperli (dostarlimab) and Zejula (niraparib). Jemperli is the first and only approved PD-1 immunotherapy for ...

A CHARITY yoga event that has raised thousands to help find a cure for cancer is set to return at the weekend. Karen Thursby, ...

AstraZeneca (($AZN)) announced an update on their ongoing clinical study. Study Overview: The DESTINY-Endometrial01 study aims to evaluate the ...

Here is our list of the 11 best cancer stocks to buy right now.

Loni Anderson’s cause of death was confirmed as metastatic uterine leiomyosarcoma, a rare and aggressive form of cancer that ...

The cause of death of the beloved 'WKRP in Cincinnati' actress, who died on Aug. 3, has finally been confirmed.